Map Details – County-level Variation in Renin-Angiotensin System Antagonist (RASA) Nonadherence Among New York

Impact Statement

Medicaid represents a priority population for targeting interventions to promote blood pressure medication adherence. Larger population centers across the state experience a higher burden of nonadherence, except for New York City (NYC).

This map highlights geographic differences in medication nonadherence among Medicaid and Medicare members in NYS, as well as variation in non-adherence between the two groups.
Key Points

Major Findings

Larger population centers across the state experience a higher burden of non-adherence, except for NYC. The burden of nonadherence is significantly greater among Medicaid members compared to Medicare members. The prevalence of RASA medication nonadherence is higher among Medicaid members compared to the Medicare Part D beneficiaries. Among NYS Medicaid members, the prevalence of RASA medication nonadherence by county ranged from a low of 27.9% in Lewis county to a high of 46.2% in Schenectady county. Among Medicare Part D beneficiaries, the prevalence of RASA medication nonadherence by county ranged from a low of 13.6% in Ontario county to a high of 24.9% in Kings county. The pattern of RASA nonadherence was similar among Medicare and Medicaid members, except for New York City (NYC).

The views and opinions expressed in this publication are those of the author(s) and do not necessarily reflect the official policy or position of the New York State Department of Health. Examples of Analysis performed within this publication are only examples. They should not be utilized in real-world analytic products.

How the map will be used, or has been used

Findings have been shared with NYS Department of Health program staff working on hypertension initiatives, including the Office of Quality and Patient Safety and the Division of Chronic Disease Prevention. This map has been used to help allocate resources to areas with a high burden of medication non-adherence.